HUMAN PERIPHERAL BLOOD LYMPHOCYTE RECONSTITUTED SEVERE COMBINED IMMUNODEFICIENT (hu-PBL-SCID) MICERyoichi Shiroki, David W. Scharp, Nancy Poı̀ndexter et al.|Transplantation|1994Cited by 38
HUMAN PERIPHERAL BLOOD LYMPHOCYTE RECONSTITUTED SEVERE COMBINED IMMUNODEFICIENT (hu-PBL-SCID) MICERyoichi Shiroki, David W. Scharp, Salman Hussain et al.|Transplantation|1994Cited by 34
Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus NivolumabYusuke Yano, Haruhito Azuma, Takaya Ohno et al.|Cancers|2022Cited by 21
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan ConsortiumTaizo Uchimoto, Haruhito Azuma, Kengo Iwatsuki et al.|International Journal of Clinical Oncology|2024Cited by 12
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial CarcinomaTaizo Uchimoto, Haruhito Azuma, Takuya Matsuda et al.|Targeted Oncology|2024Cited by 12